diarrhea-predominant irritable bowel syndrome
Conditions
Interventions
Group A1B1C1 :Basic treatment + Baihui point + moving qi acupuncture (course of disease 1-2 years)
GroupA1B1C2:Basic treatment + Baihui point + moving qi acupuncture (course of disease > 2 years)
Group A1B2C1:Basic treatment + Baihui point + Pingbu Pingxie method (course of disease 1-2 years)
Group A1B2C2 :Basic treatment + Baihui point + Pingbu Pingxie method (course of disease > 2 years)
Group A2B1C1:Basic treatment + Neiguan point + moving qi acupuncture (course of disease 1-2 years)
Group A2B1C2:Basic treatment + Neiguan point + moving qi acupuncture (course of disease > 2 years)
Group A2B2C1:Basic treatment + Neiguan point + Pingbu Pingxie method (course of disease 1-2 years)
Group A2B2C2:Basic treatment + Neiguan point + Pingbu Pingxie method (course of disease > 2 years)
Sponsors
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. 18 years old<=age<=65 years; 2. Diagnosis that meets the Rome IV diagnostic criteria for IBS-D; 3. Within the past month, there have been no abnormalities in stool routine and occult blood; 4. Newly diagnosed individuals over 50 years old, with no abnormalities on colonoscopy within 1 year; 5. IBS-D related symptoms persist for more than 1 year; 6. The total score of IBS-SSS during the baseline period is greater than 75 points; 7. Dietary control has been used for at least 6 weeks but the effect is not satisfactory; 8. Have used at least one treatment drug recommended by guidelines or expert consensus and maintained it for at least 6 weeks, but the effect is not satisfactory; 9. Voluntarily participate in this experiment and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Take any analgesics and opioid drugs such as ibuprofen and ibunarizine within 24 hours before acupuncture intervention; 2. Previous colonoscopy, barium meal fluoroscopy, abdominal ultrasound, and other examinations have found organic intestinal lesions (including but not limited to patients with ulcerative colitis, familial multiple intestinal polyps, and colorectal cancer); 3. Have one or more of the following warning symptoms: blood in stool, positive fecal occult blood test, anemia, abdominal mass, ascites, fever, unintentional weight loss, and family history of colorectal cancer or inflammatory bowel disease; 4. Those who have combined cardiovascular, endocrine, hematological, and rheumatic immune system diseases that affect the determination of their condition; 5.Individuals with unclear consciousness, inability to express subjective discomfort symptoms, and severely diagnosed mental disorders; 6. Patients with severe depression (SDS total score>56 points); 7. Pregnant or lactating women; 8. Patients who have received acupuncture treatment for IBS-D in the past three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IBS-SSS;Effective response rate at the 4th week; | — |
Secondary
| Measure | Time frame |
|---|---|
| IBS Symptom relief assessment of global IBS symptoms;Daily defecation times;Daily defecation traits;Urgency of symptoms of irritable bowel syndrome;Irritable bowel syndrome quality of life score (IBS-QOL);self-rating anxiety scale, SAS;Self-Rating Depression Scale, SDS; | — |
Countries
China
Contacts
Public ContactJinxia Ni
Dongzhimen Hospital, Beijing University of Chinese Medicine
Outcome results
None listed